SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:oru-41452"
 

Sökning: onr:"swepub:oai:DiVA.org:oru-41452" > Molecular sampling ...

Molecular sampling of prostate cancer : a dilemma for predicting disease progression

Sboner, Andrea (författare)
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven CT, USA,Yale University
Demichelis, Francesca (författare)
Department of Pathology and LaboratoryMedicine, Weill Cornell Medical Center, New York, USA; Institute for Computational Biomedicine, Weill Cornell Medical Center, New York, USA,Weill Cornell Medical Centre
Calza, Stefano (författare)
Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; Department of Biomedical Sciences and Biotechnologies, University of Brescia, Brescia, Italy,Karolinska Institute
visa fler...
Pawitan, Yudi (författare)
Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden,Karolinska Institute
Setlur, Sunita R. (författare)
Department of Pathology, Brigham and Women's Hospital, Boston MA, USA
Hoshida, Yujin (författare)
The Broad Institute of MIT and Harvard, Cambridge MA, USA; The Dana Farber Cancer Institute, Boston MA, USA,Dana Farber Cancer Institute
Perner, Sven (författare)
Department of Pathology and LaboratoryMedicine, Weill Cornell Medical Center, New York, USA,Weill Cornell Medical Centre
Adami, Hans-Olov (författare)
Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; Department of Epidemiology, Harvard School of Public Health, Boston, USA,Karolinska Institute
Fall, Katja, 1971- (författare)
Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; Department of Epidemiology, Harvard School of Public Health, Boston, USA,Karolinska Institute
Mucci, Lorelei A. (författare)
Harvard Medical School, Boston MA, USA; Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston MA, USA; Department of Epidemiology, Harvard School of Public Health, Boston MA, USA
Kantoff, Philip W. (författare)
Harvard Medical School, Boston MA, USA; The Dana Farber Cancer Institute, Boston MA, USA
Stampfer, Meir (författare)
Harvard Medical School, Boston MA, USA; Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston MA, USA; Department of Epidemiology, Harvard School of Public Health, Boston MA, USA,Harvard University
Andersson, Swen-Olof, 1949- (författare)
Department of Urology, Örebro University Hospital, Örebro, Sweden,Örebro University Hospital
Varenhorst, Eberhard (författare)
Östergötlands Läns Landsting,Linköpings universitet,Urologi,Hälsouniversitetet,Urologiska kliniken i Östergötland
Johansson, Jan-Erik (författare)
Department of Urology, Örebro University Hospital, Örebro, Sweden,Örebro University Hospital
Gerstein, Mark B. (författare)
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven CT, USA; Program in Computational Biology and Bioinformatics, Yale University, New Haven CT, USA; Department of Computer Science, Yale University, New Haven CT, USA
Golub, Todd R. (författare)
The Howard Hughes Medical Institute at The Broad Institute of MIT and Harvard, Cambridge MA, USA; The Broad Institute of MIT and Harvard, Cambridge MA, USA; The Dana Farber Cancer Institute, Boston MA, USA
Rubin, Mark A. (författare)
Medicine, Weill Cornell Medical Center, New York, USA; The Broad Institute of MIT and Harvard, Cambridge MA, USA
Andrén, Ove, 1963- (författare)
Department of Urology, Örebro University Hospital, Örebro, Sweden
Kantoff, Philip W (författare)
Dana Farber Cancer Institute
Golub, Todd R (författare)
Dana Farber Cancer Institute
A Mucci, Lorelei (författare)
Harvard University
Gerstein, Mark B (författare)
Yale University
Andren, Ove (författare)
Örebro University Hospital
Setlur, Sunita R (författare)
Brigham and Womens Hospital
Rubin, Mark A (författare)
Weill Cornell Medical Centre
Hoshida, Y (författare)
Pawitan, Y (författare)
Karolinska Institutet
Andersson, SO (författare)
Setlur, SR (författare)
Johansson, JE (författare)
Stampfer, M (författare)
Varenhorst, E (författare)
Sboner, A (författare)
Fall, K (författare)
Karolinska Institutet
Gerstein, MB (författare)
Demichelis, F (författare)
Andren, O (författare)
Mucci, LA (författare)
Adami, HO (författare)
Karolinska Institutet
Perner, S (författare)
Calza, S (författare)
Karolinska Institutet
Rubin, MA (författare)
Golub, TR (författare)
Kantoff, PW (författare)
visa färre...
 (creator_code:org_t)
London, United Kingdom : BioMed Central, 2010
2010
Engelska.
Ingår i: BMC Medical Genomics. - London, United Kingdom : BioMed Central. - 1755-8794 .- 1755-8794. ; 3
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Current prostate cancer prognostic models are based on pre-treatment prostate specific antigen (PSA) levels, biopsy Gleason score, and clinical staging but in practice are inadequate to accurately predict disease progression. Hence, we sought to develop a molecular panel for prostate cancer progression by reasoning that molecular profiles might further improve current clinical models.Methods: We analyzed a Swedish Watchful Waiting cohort with up to 30 years of clinical follow up using a novel method for gene expression profiling. This cDNA-mediated annealing, selection, ligation, and extension (DASL) method enabled the use of formalin-fixed paraffin-embedded transurethral resection of prostate (TURP) samples taken at the time of the initial diagnosis. We determined the expression profiles of 6100 genes for 281 men divided in two extreme groups: men who died of prostate cancer and men who survived more than 10 years without metastases (lethals and indolents, respectively). Several statistical and machine learning models using clinical and molecular features were evaluated for their ability to distinguish lethal from indolent cases.Results: Surprisingly, none of the predictive models using molecular profiles significantly improved over models using clinical variables only. Additional computational analysis confirmed that molecular heterogeneity within both the lethal and indolent classes is widespread in prostate cancer as compared to other types of tumors.Conclusions: The determination of the molecularly dominant tumor nodule may be limited by sampling at time of initial diagnosis, may not be present at time of initial diagnosis, or may occur as the disease progresses making the development of molecular biomarkers for prostate cancer progression challenging.

Ämnesord

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Nyckelord

MEDICINE
MEDICIN

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy